Results 51 to 60 of about 6,234 (197)

Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes [PDF]

open access: yesClinical Microbiology and Infection, 2006
Between 1 January 2003 and 31 December 2003, 37 patients had positive cultures of pandrug-resistant Pseudomonas aeruginosa (PDRPA) resistant to all commercially available anti-pseudomonal antimicrobial agents in Taiwan, including anti-pseudomonal penicillins, ceftazidime, fourth-generation cephalosporins, aztreonam, carbapenems, aminoglycosides and ...
C Y, Wang   +7 more
openaire   +3 more sources

The rise of carbapenem resistance in Europe : just the tip of the iceberg? [PDF]

open access: yes, 2013
The European Antimicrobial Resistance Surveillance Network (EARS-Net) collects data on carbapenem resistance from invasive bacterial infections. Increasing percentages of carbapenem resistance in K.
Anna-Pelagia Magiorakos   +5 more
core   +1 more source

Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen

open access: yesInternational Journal of Infectious Diseases, 2015
Infections due to carbapenemase-producing Klebsiella pneumoniae represent an emerging threat due to the high mortality rate and lack of valid antimicrobial combinations, especially when the strain is colistin-resistant.
Alessandra Oliva   +8 more
doaj   +1 more source

Antibiofilm activity of a chionodracine‐derived peptide by NMR‐based metabolomics of cell‐free supernatant of Acinetobacter baumannii clinical strains

open access: yesFEBS Open Bio, Volume 16, Issue 4, Page 751-765, April 2026.
KHS‐Cnd peptide is able to impair biofilm formation and disaggregate mature biofilms in Acinetobacter baumannii clinical isolates. Differences in extracellular metabolites reflect changes in biofilm metabolism due to KHS‐Cnd treatment. Among the differentially represented extracellular metabolites upon KHS‐Cnd treatment, the significantly altered ...
Fernando Porcelli   +9 more
wiley   +1 more source

4CPS-043 Extensively pandrug-resistant pseudomonas aeruginosa infections: analysis and outcomes [PDF]

open access: yesSection 4: Clinical Pharmacy Services, 2019
Background The incidence of infections due to extensively drug-resistant (XDR) and pandrug-resistant (PDR) strains of Pseudomonas aeruginosa (PSA)is increasing, mainly due to the overuse of antibiotics. Purpose The aim of this study was to identify and describe the infections due to XDR and PDR PSA occurring in our hospital, as well as to compare ...
M Achaques-Rodriguez   +3 more
openaire   +1 more source

Case report: Azithromycin-meropenem combination therapy as a low-cost approach to combat PDR gram-negative infections of war wounds in Ukraine

open access: yesFrontiers in Medicine, 2023
Antimicrobial resistance recognised as a major global health problem and it poses a significant challenge in conflict zones, such as the Russia-Ukraine war. This case study focuses on a 32-year-old soldier who sustained combat-related injuries, including
Vadym Kryzhevskyi   +14 more
doaj   +1 more source

Characterisation of Pseudomonas aeruginosa related to bovine mastitis [PDF]

open access: yes, 2013
Pseudomonas aeruginosa is one of the causative pathogens of bovine mastitis. Most P. aeruginosa strains possess the type III secretion system (TTSS), which may increase somatic cell counts (SCCs) in milk from mastitis-affected cows.
Hong, Min   +8 more
core   +1 more source

Potential of Eugenia brejoensis (Mazine) Essential Oil in Combating Multidrug‐Resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa

open access: yesChemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT The genus Eugenia has a long history of use in traditional medicine for treating various conditions, including infectious diseases, gastrointestinal disorders, and skin problems. Essential oils derived from Eugenia species are known for their medicinal properties and have been studied for their antimicrobial and bioactive potential. This study
Jonathan Mandú de Araújo   +10 more
wiley   +1 more source

Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe [PDF]

open access: yesEurosurveillance, 2008
International and local surveillance networks as well as numerous reports in the biomedical literature provide evidence that the prevalence of antibiotic resistant Gram-negative bacteria is escalating in many European countries. Furthermore, isolates characterised as multidrug-resistant (i.e.
M, Souli, I, Galani, H, Giamarellou
openaire   +2 more sources

Home - About - Disclaimer - Privacy